Skip to main content
Erschienen in: Endocrine 2/2017

07.07.2016 | Original Article

Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren

verfasst von: Giuseppe Murdolo, Cristina Tortoioli, Federica Celi, Vittorio Bini, Francesco Papi, Annalisa Brozzetti, Alberto Falorni

Erschienen in: Endocrine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The secreted hepatokine fetuin-A emerges as an independent predictor of type 2 diabetes in adulthood. The overall aims of this study were: (1) to investigate the associations of fetuin-A with adiposity and insulin resistance, as well as its relationship with adipokines, in prepubertal children, and, (2) to evaluate whether, in prepubertal obesity, serum fetuin-A levels may either change or predict the responsiveness to an educational-based weight excess reduction program. We studied 200 prepubertal children (boys/girls: 89/111; Tanner stage 1; age: 5–13 years), included in a cohort of 44,231 adolescents who participated in an extensive Italian school-based survey. According to Cole’s criteria, 100 individuals were lean (boys/girls: 57/43) and 100 obese (boys/girls: 54/46). A subset of 53 obese individuals (boys/girls: 28/25; age: 6–12 years) were also evaluated after a weight excess reduction program. Serum fetuin-A, leptin, total and high molecular weight adiponectin levels, as well as homeostasis model assessment of insulin resistance were assessed. When compared with lean, obese children exhibited higher ( p < 0.0001) fetuin-A concentrations, without differences between sex. Fetuin-A was positively associated with adiposity, homeostasis model assessment of insulin resistance, and leptin levels. In multivariate analysis, the associations between fetuin-A and leptin or homeostasis model assessment of insulin resistance lost the significance after adjustment for BMI Z-score, which, in turn, represented an independent determinant of fetuin-A (R 2 adj 0.327; p < 0.0001). Notably, after weight excess reduction program, fetuin-A levels dropped ( p < 0.0001 vs. basal). Interestingly, no significant differences of fetuin-A concentrations between responders and no responders were found. In prepubertal children, fetuin-A represents an early marker of adiposity, and its reduction after lifestyle intervention may partly contribute to the beneficial effects of weight excess reduction program.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat J.L. Baker, L.W. Olsen, T.I. Sorensen, Childhood body-mass index and the risk of coronary heart disease in adulthood. N. Engl. J. Med. 357, 2329–2337 (2007)CrossRef J.L. Baker, L.W. Olsen, T.I. Sorensen, Childhood body-mass index and the risk of coronary heart disease in adulthood. N. Engl. J. Med. 357, 2329–2337 (2007)CrossRef
2.
Zurück zum Zitat J.C. Winer, T.L. Zern, S.E. Taksali, J. Dziura, A.M. Cali, M. Wollschlager, A.A. Seyal, R. Weiss, T.S. Burgert, S. Caprio, Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J. Clin. Endocrinol. Metab. 91(11), 4415–4423 (2006)CrossRef J.C. Winer, T.L. Zern, S.E. Taksali, J. Dziura, A.M. Cali, M. Wollschlager, A.A. Seyal, R. Weiss, T.S. Burgert, S. Caprio, Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J. Clin. Endocrinol. Metab. 91(11), 4415–4423 (2006)CrossRef
3.
Zurück zum Zitat A. Sbarbati, F. Osculati, D. Silvagni, D. Benati, M. Galie, F.S. Camoglio, G. Rigotti, C. Maffeis, Obesity and inflammation: evidence for an elementary lesion. Pediatrics 117(1), 220–223 (2006)CrossRef A. Sbarbati, F. Osculati, D. Silvagni, D. Benati, M. Galie, F.S. Camoglio, G. Rigotti, C. Maffeis, Obesity and inflammation: evidence for an elementary lesion. Pediatrics 117(1), 220–223 (2006)CrossRef
4.
Zurück zum Zitat M. Sabin, J. Holly, J. Shield, S. Turner, M. Grohmann, C. Stewart, E. Crowne, Mature subcutaneous and visceral adipocyte concentrations of adiponectin are highly correlated in prepubertal children and inversely related to body mass index standard deviation score. J. Clin. Endocrinol. Metab. 91, 332–335 (2006)CrossRef M. Sabin, J. Holly, J. Shield, S. Turner, M. Grohmann, C. Stewart, E. Crowne, Mature subcutaneous and visceral adipocyte concentrations of adiponectin are highly correlated in prepubertal children and inversely related to body mass index standard deviation score. J. Clin. Endocrinol. Metab. 91, 332–335 (2006)CrossRef
5.
Zurück zum Zitat M. Valle, R. Martos, F. Gascon, R. Canete, M.A. Zafra, R. Morales, Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 31(1), 55–62 (2005)CrossRef M. Valle, R. Martos, F. Gascon, R. Canete, M.A. Zafra, R. Morales, Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 31(1), 55–62 (2005)CrossRef
6.
Zurück zum Zitat S.H. Ley, S.B. Harris, P.W. Connelly, M. Mamakeesick, J. Gittelsohn, R.A. Hegele, R. Retnakaran, B. Zinman, A.J. Hanley, Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care 31(7), 1410–1415 (2008)CrossRef S.H. Ley, S.B. Harris, P.W. Connelly, M. Mamakeesick, J. Gittelsohn, R.A. Hegele, R. Retnakaran, B. Zinman, A.J. Hanley, Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care 31(7), 1410–1415 (2008)CrossRef
7.
Zurück zum Zitat Y. Wang, K.S. Lam, M.H. Yau, A. Xu, Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 409(3), 623–633 (2008)CrossRef Y. Wang, K.S. Lam, M.H. Yau, A. Xu, Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 409(3), 623–633 (2008)CrossRef
8.
Zurück zum Zitat N. Stefan, H. HU, The metabolically benign and malignant fatty liver. Diabetes 60, 2011–2017 (2011)CrossRef N. Stefan, H. HU, The metabolically benign and malignant fatty liver. Diabetes 60, 2011–2017 (2011)CrossRef
9.
Zurück zum Zitat N. Stefan, H.U. Haring, The role of hepatokines in metabolism. Nat. Rev. Endocrinol. 9(3), 144–152 (2013)CrossRef N. Stefan, H.U. Haring, The role of hepatokines in metabolism. Nat. Rev. Endocrinol. 9(3), 144–152 (2013)CrossRef
10.
Zurück zum Zitat C. Weikert, N. Stefan, M.B. Schulze, T. Pischon, K. Berger, H.G. Joost, H.U. Haring, H. Boeing, A. Fritsche, Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118(24), 2555–2562 (2008)CrossRef C. Weikert, N. Stefan, M.B. Schulze, T. Pischon, K. Berger, H.G. Joost, H.U. Haring, H. Boeing, A. Fritsche, Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118(24), 2555–2562 (2008)CrossRef
11.
Zurück zum Zitat A. Iroz, J.-P. Couty, C. Postic, Hepatokines: unlocking the multi-organ network in metabolic diseases. Diabetologia 58, 1699–1703 (2015)CrossRef A. Iroz, J.-P. Couty, C. Postic, Hepatokines: unlocking the multi-organ network in metabolic diseases. Diabetologia 58, 1699–1703 (2015)CrossRef
12.
Zurück zum Zitat L. Kalabay, K. Chavin, J. Lebreton, K. Robinson, M. Buse, P. Arnaud, Human recombinant alpha 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase. Horm. Metab. Res. 30, 1–6 (1998)CrossRef L. Kalabay, K. Chavin, J. Lebreton, K. Robinson, M. Buse, P. Arnaud, Human recombinant alpha 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase. Horm. Metab. Res. 30, 1–6 (1998)CrossRef
13.
Zurück zum Zitat T. Reinehr, C.L. Roth, Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 93(11), 4479–4485 (2008)CrossRef T. Reinehr, C.L. Roth, Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 93(11), 4479–4485 (2008)CrossRef
14.
Zurück zum Zitat N. Stefan, Q. Sun, A. Fritsche, J. Machann, F. Schick, F. Gerst, C. Jeppesen, H.G. Joost, F.B. Hu, H. Boeing, S. Ullrich, H.U. Haring, M.B. Schulze, Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One 9(3), e92238 (2014)CrossRef N. Stefan, Q. Sun, A. Fritsche, J. Machann, F. Schick, F. Gerst, C. Jeppesen, H.G. Joost, F.B. Hu, H. Boeing, S. Ullrich, H.U. Haring, M.B. Schulze, Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One 9(3), e92238 (2014)CrossRef
15.
Zurück zum Zitat A.M. Hennige, H. Staiger, C. Wicke, F. Machicao, A. Fritsche, H.U. Haring, N. Stefan, Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 3(3), e1765 (2008)CrossRef A.M. Hennige, H. Staiger, C. Wicke, F. Machicao, A. Fritsche, H.U. Haring, N. Stefan, Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 3(3), e1765 (2008)CrossRef
16.
Zurück zum Zitat J.H. Ix, C.L. Wassel, A.M. Kanaya, E. Vittinghoff, K.C. Johnson, A. Koster, J.A. Cauley, T.B. Harris, S.R. Cummings, M.G. Shlipak, Fetuin-A and incident diabetes mellitus in older persons. J. Am. Med. Assoc. 300(2), 182–188 (2008)CrossRef J.H. Ix, C.L. Wassel, A.M. Kanaya, E. Vittinghoff, K.C. Johnson, A. Koster, J.A. Cauley, T.B. Harris, S.R. Cummings, M.G. Shlipak, Fetuin-A and incident diabetes mellitus in older persons. J. Am. Med. Assoc. 300(2), 182–188 (2008)CrossRef
17.
Zurück zum Zitat T. Reinehr, B. Karges, T. Meissner, S. Wiegand, M. Fritsch, H. RWeinhard, J. Woelfle, Fibroblast growth factor 21 and fetuin-A in obese adolescents with and without type 2 diabetes. J. Clin. Endocrinol. Metab. 100, 3004–3010 (2015)CrossRef T. Reinehr, B. Karges, T. Meissner, S. Wiegand, M. Fritsch, H. RWeinhard, J. Woelfle, Fibroblast growth factor 21 and fetuin-A in obese adolescents with and without type 2 diabetes. J. Clin. Endocrinol. Metab. 100, 3004–3010 (2015)CrossRef
18.
Zurück zum Zitat T. Reinehr, B. Stoffel-Wagner, C.L. Roth, Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metabolism 56(12), 1735–1741 (2007)CrossRef T. Reinehr, B. Stoffel-Wagner, C.L. Roth, Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metabolism 56(12), 1735–1741 (2007)CrossRef
19.
Zurück zum Zitat J.M. Brix, H. Stingl, F. Hollerl, G.H. Schernthaner, H.P. Kopp, G. Schernthaner, Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J. Clin. Endocrinol. Metab. 95(11), 4877–4881 (2010)CrossRef J.M. Brix, H. Stingl, F. Hollerl, G.H. Schernthaner, H.P. Kopp, G. Schernthaner, Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J. Clin. Endocrinol. Metab. 95(11), 4877–4881 (2010)CrossRef
20.
Zurück zum Zitat T. Reinehr, J. Kratzsch, W. Kiess, W. Andler, Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int. J. Obes. (Lond.) 29(10), 1230–1235 (2005)CrossRef T. Reinehr, J. Kratzsch, W. Kiess, W. Andler, Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int. J. Obes. (Lond.) 29(10), 1230–1235 (2005)CrossRef
21.
Zurück zum Zitat G. Di Stefano, V. Bini, F. Papi, F. Celi, G. Contessa, M.G. Berioli, M.L. Bacosi, A. Falorni, Leptin serum concentrations predict the responsiveness of obese children and adolescents to weight excess reduction program. Int. J. Obes. Relat. Metab. Disord. 24(12), 1586–1591 (2000)CrossRef G. Di Stefano, V. Bini, F. Papi, F. Celi, G. Contessa, M.G. Berioli, M.L. Bacosi, A. Falorni, Leptin serum concentrations predict the responsiveness of obese children and adolescents to weight excess reduction program. Int. J. Obes. Relat. Metab. Disord. 24(12), 1586–1591 (2000)CrossRef
22.
Zurück zum Zitat G. Murdolo, B. Nowotny, F. Celi, M. Donati, V. Bini, F. Papi, G. Gornitzka, S. Castellani, M. Roden, A. Falorni, C. Herder, A. Falorni, Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren. PLoS One 6(2), e17264 (2011)CrossRef G. Murdolo, B. Nowotny, F. Celi, M. Donati, V. Bini, F. Papi, G. Gornitzka, S. Castellani, M. Roden, A. Falorni, C. Herder, A. Falorni, Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren. PLoS One 6(2), e17264 (2011)CrossRef
23.
Zurück zum Zitat F. Celi, V. Bini, G. De Giorgi, D. Molinari, F. Faraoni, G. Di Stefano, M.L. Bacosi, M.G. Berioli, G. Contessa, A. Falorni, Epidemiology of overweight and obesity among school children and adolescents in three provinces of central Italy, 1993–2001: study of potential influencing variables. Eur. J. Clin. Nutr. 57, 1045–1051 (2003)CrossRef F. Celi, V. Bini, G. De Giorgi, D. Molinari, F. Faraoni, G. Di Stefano, M.L. Bacosi, M.G. Berioli, G. Contessa, A. Falorni, Epidemiology of overweight and obesity among school children and adolescents in three provinces of central Italy, 1993–2001: study of potential influencing variables. Eur. J. Clin. Nutr. 57, 1045–1051 (2003)CrossRef
24.
Zurück zum Zitat A. Falorni, G. Galmacci, V. Bini, F. Papi, D. Molinari, G. De Giorgi, F. Faraoni, F. Celi, G. Di Stefano, M.G. Berioli, G. Contessa, M.L. Bacosi, Fasting serum leptin levels in the analysis of body mass index cut-off values: are they useful for overweight screening in children and adolescents? A school population-based survey in three provinces of central Italy. Int. J. Obes. Relat. Metab. Disord. 22(12), 1197–1208 (1998)CrossRef A. Falorni, G. Galmacci, V. Bini, F. Papi, D. Molinari, G. De Giorgi, F. Faraoni, F. Celi, G. Di Stefano, M.G. Berioli, G. Contessa, M.L. Bacosi, Fasting serum leptin levels in the analysis of body mass index cut-off values: are they useful for overweight screening in children and adolescents? A school population-based survey in three provinces of central Italy. Int. J. Obes. Relat. Metab. Disord. 22(12), 1197–1208 (1998)CrossRef
25.
Zurück zum Zitat A. Falorni, V. Bini, D. Molinari, F. Papi, F. Celi, G. Di Stefano, M.G. Berioli, M.L. Bacosi, G. Contessa, Leptin serum levels in normal weight and obese children and adolescents: relationship with age, sex, pubertal development, body mass index and insulin. Int. J. Obes. Relat. Metab. Disord. 21(10), 881–890 (1997)CrossRef A. Falorni, V. Bini, D. Molinari, F. Papi, F. Celi, G. Di Stefano, M.G. Berioli, M.L. Bacosi, G. Contessa, Leptin serum levels in normal weight and obese children and adolescents: relationship with age, sex, pubertal development, body mass index and insulin. Int. J. Obes. Relat. Metab. Disord. 21(10), 881–890 (1997)CrossRef
26.
Zurück zum Zitat T.J. Cole, M.C. Bellizzi, K.M. Flegal, W.H. Dietz, Establishing a standard definition for child overweight and obesity worldwide: international survey. Br. Med. J. 320(7244), 1240–1243 (2000)CrossRef T.J. Cole, M.C. Bellizzi, K.M. Flegal, W.H. Dietz, Establishing a standard definition for child overweight and obesity worldwide: international survey. Br. Med. J. 320(7244), 1240–1243 (2000)CrossRef
27.
Zurück zum Zitat F. Abbasi, J. Chu, C. Lamendola, T. McLaughlin, J. Hayden, G. Reaven, P. Reaven, Discrimination between obesity and insulin-resistance in the relationship with adiponectin. Diabetes 53, 585–590 (2004)CrossRef F. Abbasi, J. Chu, C. Lamendola, T. McLaughlin, J. Hayden, G. Reaven, P. Reaven, Discrimination between obesity and insulin-resistance in the relationship with adiponectin. Diabetes 53, 585–590 (2004)CrossRef
28.
Zurück zum Zitat S. Araki, K. Dobashi, K. Kubo, K. Asayama, A. Shirahata, High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J. Clin. Endocrinol. Metab. 91(12), 5113–5116 (2006)CrossRef S. Araki, K. Dobashi, K. Kubo, K. Asayama, A. Shirahata, High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J. Clin. Endocrinol. Metab. 91(12), 5113–5116 (2006)CrossRef
29.
Zurück zum Zitat H. Mangge, G. Almer, S. Haj-Yahya, S. Pilz, R. Gasser, R. Moller, R. Horejsi, Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity (Silver Spring) 16(12), 2578–2584 (2008)CrossRef H. Mangge, G. Almer, S. Haj-Yahya, S. Pilz, R. Gasser, R. Moller, R. Horejsi, Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity (Silver Spring) 16(12), 2578–2584 (2008)CrossRef
30.
Zurück zum Zitat P.L. Tsou, Y.D. Jiang, C.C. Chang, J.N. Wei, F.C. Sung, C.C. Lin, C.C. Chiang, T.Y. Tai, L.M. Chuang, Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 27(2), 308–313 (2004)CrossRef P.L. Tsou, Y.D. Jiang, C.C. Chang, J.N. Wei, F.C. Sung, C.C. Lin, C.C. Chiang, T.Y. Tai, L.M. Chuang, Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 27(2), 308–313 (2004)CrossRef
31.
Zurück zum Zitat K.K. Andersen, J. Frystyk, O.D. Wolthers, C. Heuck, A. Flyvbjerg, Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J. Clin. Endocrinol. Metab. 92(5), 1857–1862 (2007)CrossRef K.K. Andersen, J. Frystyk, O.D. Wolthers, C. Heuck, A. Flyvbjerg, Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J. Clin. Endocrinol. Metab. 92(5), 1857–1862 (2007)CrossRef
32.
Zurück zum Zitat A. Bottner, J. Kratzsch, G. Muller, T.M. Kapellen, S. Bluher, E. Keller, M. Bluher, W. Kiess, Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab. 89(8), 4053–4061 (2004)CrossRef A. Bottner, J. Kratzsch, G. Muller, T.M. Kapellen, S. Bluher, E. Keller, M. Bluher, W. Kiess, Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab. 89(8), 4053–4061 (2004)CrossRef
33.
Zurück zum Zitat A.M. Wallace, A.D. McMahon, C.J. Packard, A. Kelly, J. Shepherd, A. Gaw, N. Sattar, Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104(25), 3052–3056 (2001)CrossRef A.M. Wallace, A.D. McMahon, C.J. Packard, A. Kelly, J. Shepherd, A. Gaw, N. Sattar, Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104(25), 3052–3056 (2001)CrossRef
34.
Zurück zum Zitat N. Satoh, M. Naruse, T. Usui, T. Tagami, T. Suganami, K. Yamada, H. Kuzuya, A. Shimatsu, Y. Ogawa, Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27(10), 2488–2490 (2004)CrossRef N. Satoh, M. Naruse, T. Usui, T. Tagami, T. Suganami, K. Yamada, H. Kuzuya, A. Shimatsu, Y. Ogawa, Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27(10), 2488–2490 (2004)CrossRef
35.
Zurück zum Zitat N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Krober, F. Machicao, A. Fritsche, H.U. Haring, Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4), 853–857 (2006)CrossRef N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Krober, F. Machicao, A. Fritsche, H.U. Haring, Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4), 853–857 (2006)CrossRef
36.
Zurück zum Zitat I. Dahlman, P. Eriksson, M. Kaaman, H. Jiao, C.M. Lindgren, J. Kere, P. Arner, Alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 47(11), 1974–1979 (2004)CrossRef I. Dahlman, P. Eriksson, M. Kaaman, H. Jiao, C.M. Lindgren, J. Kere, P. Arner, Alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 47(11), 1974–1979 (2004)CrossRef
37.
Zurück zum Zitat A. Siddiq, F. Lepretre, S. Hercberg, P. Froguel, F. Gibson, A synonymous coding polymorphism in the alpha2-Heremans-Schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes 54(8), 2477–2481 (2005)CrossRef A. Siddiq, F. Lepretre, S. Hercberg, P. Froguel, F. Gibson, A synonymous coding polymorphism in the alpha2-Heremans-Schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes 54(8), 2477–2481 (2005)CrossRef
38.
Zurück zum Zitat L. Groop, C. Forsblom, M. Lehtovirta, T. Tuomi, S. Karanko, M. Nissen, B.O. Ehrnstrom, B. Forsen, B. Isomaa, B. Snickars, M.R. Taskinen, Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45(11), 1585–1593 (1996)CrossRef L. Groop, C. Forsblom, M. Lehtovirta, T. Tuomi, S. Karanko, M. Nissen, B.O. Ehrnstrom, B. Forsen, B. Isomaa, B. Snickars, M.R. Taskinen, Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45(11), 1585–1593 (1996)CrossRef
39.
Zurück zum Zitat J. Hwang, B. Thakkar, J. Chamberland, C. Mantzoros, Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration. Metabolism 63, 754–759 (2014)CrossRef J. Hwang, B. Thakkar, J. Chamberland, C. Mantzoros, Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration. Metabolism 63, 754–759 (2014)CrossRef
40.
Zurück zum Zitat B. Gustafson, A. Hammarstedt, C. Andersson, U. Smith, Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2276–2283 (2007)CrossRef B. Gustafson, A. Hammarstedt, C. Andersson, U. Smith, Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2276–2283 (2007)CrossRef
Metadaten
Titel
Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren
verfasst von
Giuseppe Murdolo
Cristina Tortoioli
Federica Celi
Vittorio Bini
Francesco Papi
Annalisa Brozzetti
Alberto Falorni
Publikationsdatum
07.07.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1009-3

Weitere Artikel der Ausgabe 2/2017

Endocrine 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.